In ₹ Crore except Per Share Latest Annual | ARTEMISMED FY26 | INDRAMEDCO FY26 | SHALBY FY26 | GKSL FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 52.90× | ◆ 18.00× | 44.97× | 69.84× | 44.97× +18% | |
| P/B | 5.84× | 4.46× | ◆ 1.55× | 5.38× | 4.46× +31% | |
| EV/EBITDA | 30.22× | ◆ 12.36× | 14.13× | 50.98× | 14.13× +114% | |
| Market Cap | ₹5,493 Cr | ₹3,305 Cr | ₹1,562 Cr | ₹1,371 Cr | ₹1,562 Cr +252% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ 13.61% | 10.50% | 12.35% | — | 11.43% +19% | |
| Revenue CAGR 5Y | ◆ 21.50% | 19.30% | — | — | 19.30% +11% | |
| Net Income CAGR 3Y | ◆ 39.74% | 28.69% | -19.97% | — | 4.36% +811% | |
| Revenue YoY (latest Q) | ◆ 12.69% | 11.26% | 11.74% | — | 11.50% +10% | |
| Net Income YoY (latest Q) | ◆ 48.33% | 8.53% | 36.70% | — | 22.62% +114% | |
| Profitability | ||||||
| EBITDA Margin | 17.40% | 18.00% | 12.51% | ◆ 32.85% | 18.00% -3% | |
| Net Income Margin | 9.59% | 12.39% | 3.04% | ◆ 20.50% | 12.39% -23% | |
| Return on Common Equity | 11.02% | ◆ 24.80% | 3.72% | 6.08% | 6.08% +81% | |
| Return on Capital Employed | 11.50% | ◆ 27.17% | 5.76% | 8.24% | 8.24% +40% | |
| Return on Assets | 7.26% | ◆ 18.52% | 1.89% | 5.65% | 5.65% +28% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.24× | ◆ 0.00× | 0.54× | 0.06× | 0.06× +300% | |
| Interest Coverage | 5.06× | ◆ 37.09× | 1.87× | 11.84× | 11.84× -57% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹1,081 Cr | ₹1,483 Cr | ₹1,141 Cr | ₹82 Cr | ₹1,141 Cr -5% | |
| Net Income | ₹104 Cr | ₹184 Cr | ₹34.7 Cr | ₹16.8 Cr | ₹34.7 Cr +199% | |
| Total Assets | ₹1,429 Cr | ₹991 Cr | ₹1,839 Cr | ₹298 Cr | ₹991 Cr +44% | |
| EPS | ₹6.56 | ₹20.03 | ₹3.23 | ₹2.49 | ₹3.23 +103% | |
| Book Value per Share | ₹59.42 | ₹80.76 | ₹93.54 | ₹32.31 | ₹80.76 -26% | |